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5.7
Chondrocytes versus fresh bone marrow implantation for cartilage 
repair - 3 year follow-up.
K. Slynarski1, R. Andrysiak2, S. Concaro3, J. Deszczynski4;
1Adult Orthopedics, CMKP, SPSK Gruca, Warszawa, Poland, 
2Nuclear Medicine, Warsaw Medical University, Warszawa, Poland, 
3Departmant Of Orthopaedics, Gothenburg University, Gothenburg, 
Sweden, 4Departament Of Orthopedic Surgery And Rehabilitation 
2nd Medical Faculty Of Warsaw Medical University, Warsaw Medcial 
University, Warsaw, Poland
Purpose: The aim of work was to analyze clinical effectiveness of 
fresh bone marrow and periosteum versus autologous chondrocytes 
in treatment of traumatic and degenerative cartilage defects. 
Methods and Materials: There were 30 patients involved into this 
study, with mean age of 37 years. Patients were randomly operated 
either with chondrocytes or fresh bone marrow. Bone marrow was 
aspirated from iliac crest and implanted under the periosteum 
sutured over the defect. Chondrocytes were isolated, cultured, 
than implanted under collagen membrane. Patients followed same 
rehabilitation protocol. At 12, 24 and 36 months postoperatively, 
patients were evaluated with analogue pain scale, Brittberg-
Peterson VAS score, Lysholm and IKDC questionnaires. Patients were 
evaluated with MRI 3 and 12 and 24 months postoperatively. In 3 
patients of each group tissue samples were obtained for histological 
assessment. 
Results: After 36 months, 12 patients treated with bone marrow were 
DMBTTJ¾FEBTOPSNBMPSOFBSMZOPSNBMJO*,%$FYBNJOBUJPOGPSNBOE
BTBCOPSNBM"MMQBUJFOUTUSFBUFEXJUIDIPOESPDZUFTXFSFDMBTTJ¾FE
as normal. In both groups MRI revealed surface with correct contour 
and continuity, without changes in subchondral bone in all but one 
patient treated with bone marrow. All histology samples revealed 
good cartilage-like regeneration. 
Conclusions: In our opinion, there is need for introduction of 
biological therapies that avoid manipulations outside the surgical 
SPPN XIBU XPVME TJHOJ¾DBOUMZ SFEVDF UIF DPTUT BOE SJTL *O UIJT
study clinical results of bone marrow and periosteum combination 
in treatment of symptomatic, full thickness cartilage defects were 
compared with autologous chondrocytes implantation, without 
TJHOJ¾DBOUEJGGFSFODFT
5.8
7 Year sequential clinical outcome improvement following 
autologous chondrocyte implantation
J.M. Jagiello1, B. Rogers2, L. David3, T. Briggs3;
1Bone Tumour Unit, Royal National Orthopaedic Hospital, 4LP,
Middlesex, United Kingdom, 2, 3Joint Reconstruction Unit, Royal 
National Orthopaedic Hospital, London, United Kingdom
Purpose: Autologous chondrocyte implantation is being increasingly 
used for symptomatic cartilage defects in the knee but durability of 
graft survival has been questioned. This prospective 7-year study 
reviews and compares the clinical outcome of ACI. Results showed 
TJHOJ¾DBOU JNQSPWFNFOUT JO DMJOJDBM SBUJOH TDPSFT DPNQBSFE UP
pre-operative levels (p<0.0001) with ongoing annual sequential 
improvement. 
Methods and Materials: This prospective cohort study was 
conducted to evaluate articular cartilage repair using autologous 
chondrocyte implantation (ACI) performed within a single centre by a 
single surgeon with prior ethics approval being obtained. We present 
the clinical outcomes of 61 knees that have undergone autologous 
chondrocyte implantation since July 1998. Mean follow up was 39.4 
mths (13 m -7 yrs). The two stage operative technique involves 
JNQMBOUBUJPO PG DIPOESPDZUFT BT B ¿VJE DFMM TVTQFOTJPO VOEFS B
porcine biodegradable membrane(collagen I/III biomembrane). 
Patients were subsequently assessed on an annual basis using 7 
independent validated clinical rating scores. 
Results: ~Mean age at surgery was 32 years (15-51), 38 Males and 
23 Females (M:F=1.7:1). Average size of defect was 3.19 cm2 (1 to 

 .PEJ¾FE $JODJOOBUJ 	.$34
 1BUJFOU 'VODUJPOBM 0VUDPNF BOE
-ZTIPMN  (JMDISJTU DMJOJDBM SBUJOH TDPSFT BMM TIPXFE TJHOJ¾DBOU
improvements compared to pre-operative levels (p<0.0001). 
Visual Analogue Score and Bentley Functional rating score showed 
TJHOJ¾DBOU JNQSPWFNFOUT DPNQBSFE UP QSFPQFSBUJWF MFWFMT
(p<0.0001) with ongoing annual sequential improvement. Patient 
Rating and Brittberg scores, both subjective patient scores, similarly 
showed continuing improvements.~ 
Conclusions: "$*QSPEVDFTTJHOJ¾DBOUJNQSPWFNFOUTJOLOFFGVODUJPO
when compared to pre-operative levels with continued sequential 
improvement in outcomes for up to seven years. 
6.3
Evaluating knee function in patients treated with characterized 
chondrocyte implantation and microfracture, following an identical, 
standardized rehab protocol.
D. Van Assche1, D. Van Caspel2, F. Staes3, J. Vanlauwe4, J. Bellemans4,
D.B. Saris5, F. Luyten6;
1Departement Of Musculoskeletal Sciences, University Hospital, 
Katholic University of Leuven, Leuven, Belgium, 2Department 
Of Orthopaedics, University Medical Center Utrecht, Utrecht, 
Netherlands, 3Rehabilitation Science, Faculty of Kinesiology and 
Rehabilitation Sciences, Leuven, Belgium, 4Orthopaedic Surgery, 
University Hospital Leuven, Leuven, Belgium, 5Orthopaedics, 
University Medical Center, Utrecht, Utrecht, Netherlands, 
6Rheumatology, University Hospital Leuven, Leuven, Belgium
Purpose: It may be expected that a two-step open surgery with characterized 
chondrocyte implantation (CCI) would be disadvantageous to the pace of 
knee function recovery compared to a one-step arthroscopic microfracture 
procedure. The objective was to assess the index knee function in patients 
following an identical, standardized rehab protocol, as part of a prospective 
randomized clinical trial comparing CCI to microfracture in treating 
symptomatic cartilage defects of the knee. 
Methods and Materials: CCI (N=51) and microfracture (N=61) patients were 
assessed preoperatively and at 6, 9, and 12 months post operatively. Mobility 
(AROM), Anterior Laxity (with KT1000), Isokinetic Strength (by peak torque 
at 60°) and Functionality (with a single hop, the crossover triple hop and 
timed hop test) were evaluated. Of 112 evaluable patients, 100 completed 
the mobility tests, 85 the functional tests, 75 the strength tests and 65 of 
the patients completed the anterior laxity tests. Completion rate was equally 
divided among both groups. 
Results: 5IFSFXFSFOPTJHOJ¾DBOUEJGGFSFODFT JOLOFF GVODUJPOCFUXFFO
both treatment groups preoperatively. Also at 6, 9 and 12 months no 
TJHOJ¾DBOU EJGGFSFODFT XFSF PCTFSWFE CFUXFFO USFBUNFOU HSPVQT GPS BMM
four tests, except at 9 months the difference for quadriceps strength for the 
microfracture group (Med =186) compared to the CCI group (Med= 144) was 
TJHOJ¾DBOU	Q
*OHFOFSBMUIFLOFFGVODUJPOSFDPWFSFEBUNPOUIT
Conclusions: Under comparable rehabilitation conditions, the results 
EFNPOTUSBUFUIBUUIFJO¿VFODFPGUIFEJGGFSFOUTVSHJDBMQSPDFEVSFXBTOPU
TJHOJ¾DBOUPOUIFGVODUJPOPGUIFLOFFBUNPOUIT
6.4
Clinical and radiographic outcome following autologous 
chondrocyte implantation: comparison of traditional and 
accelerated approaches to post-operative rehabilitation.
J.R. Ebert1, W.B. Robertson2, T.R. Ackland3, D.J. Wood4, D.G. Lloyd5;
1Hollywood Functional Rehabilitation Clinic, Perth, Western 
Australia, Australia, 2School Of Surgery & Pathology (orthopaedics) 
And School Of Human Movement & Exercise Science, University 
of Western Australia, Perth, Western Australia, Australia, 3School
Of Human Movement & Exercise Science, University of Western 
Australia, Perth, Western Australia, Australia, 4School Of Surgery 
& Pathology (orthopaedics), University of Western Australia, 
Perth, Western Australia, Australia, 5School Of Human Movement 
And Exercise Science, The University of Western Australia, Perth, 
Australia
Purpose: Policies on post-operative load bearing rehabilitation following 
autologous chondrocyte implantation are varied and the subject remains 
controversial. We have compared an ‘accelerated’ weight bearing programme 
with a ‘traditional’ 12 week programme following matrix induced autologous 
chondrocyte implantation (MACI). 
Methods and Materials: Fifty-eight patients with full-thickness medial or 
lateral femoral condyle defects participated in this randomized controlled 
trial. Following MACI, both rehabilitation interventions sought to protect the 
implant for an initial period, then incrementally increased the load over a 12-
week period. Under the ‘accelerated’ protocol, patients reached full weight 
bearing at 8 weeks post-surgery, compared to 11 weeks for the ‘traditional’ 
group. Clinical and radiographic outcomes were undertaken at three months 
post-surgery. 
Results: Patients in the ‘accelerated’ group achieved greater six minute walk 
distances and daily activity levels as measured by accelerometry (p<0.05) 
compared to the ‘traditional’ group. Furthermore, the ‘accelerated’ group 
reported significantly better scores for the KOOS pain and symptoms subscales 
at 12-weeks (p<0.05), and there were no apparent adverse functional 
outcomes for this group. Regardless of the rehabilitation protocol employed, 
no patient suffered any adverse effect to the implant as assessed by MRI at 
three months. 
Conclusions: The ‘accelerated’ load bearing approach that reduced the 
length of time spent ambulating on crutches was not detrimental to post-
operative outcome, resulting in reduced knee pain, improved function and no 
graft complications. Patient follow-up is required to observe long-term graft 
outcomes. 
